Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- IMscin002
A Study to Evaluate Participant and Healthcare Professional Reported Preference for Subcutaneous Atezolizumab Compared With Intravenous Atezolizumab Formulation in Participants With Non-Small Cell Lung Cancer
Cancer Lung Cancer Non-Small Cell Lung Cancer (NSCLC) Non Small Cell Lung Carcinoma
Study results
LPS MO43576 IMscin002 Final Results June 2025 English
(PDF, 1.0 MB)
LPS MO43576 IMscin002 Final Results June 2025 Argentina Spanish
(PDF, 0.9 MB)
LPS MO43576 IMscin002 Final Results June 2025 Chile Spanish
(PDF, 0.9 MB)
LPS MO43576 IMscin002 Final Results June 2025 Costa Rica Spanish
(PDF, 0.9 MB)
LPS MO43576 IMscin002 Final Results June 2025 Spain Spanish
(PDF, 0.9 MB)
LPS MO43576 IMscin002 Final Results June 2025 Finnish
(PDF, 0.9 MB)
LPS MO43576 IMscin002 Final Results June 2025 Canada French
(PDF, 0.9 MB)
LPS MO43576 IMscin002 Final Results June 2025 Italian
(PDF, 0.9 MB)
LPS MO43576 IMscin002 Final Results June 2025 Korean
(PDF, 1.1 MB)
LPS MO43576 IMscin002 Final Results June 2025 Latvian
(PDF, 0.9 MB)
LPS MO43576 IMscin002 Final Results June 2025 Polish
(PDF, 0.9 MB)
LPS MO43576 IMscin002 Final Results June 2025 Ukrainian
(PDF, 1.3 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com